Brokerages expect that Henry Schein, Inc. (NASDAQ:HSIC) will announce earnings of $0.92 per share for the current quarter, Zacks reports. Nine analysts have made estimates for Henry Schein’s earnings, with the highest EPS estimate coming in at $0.96 and the lowest estimate coming in at $0.91. Henry Schein reported earnings of $0.88 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.5%. The business is expected to report its next quarterly earnings results on Tuesday, May 8th.
On average, analysts expect that Henry Schein will report full year earnings of $4.09 per share for the current year, with EPS estimates ranging from $3.99 to $4.15. For the next year, analysts forecast that the business will post earnings of $4.45 per share, with EPS estimates ranging from $4.12 to $4.55. Zacks’ EPS averages are an average based on a survey of research analysts that cover Henry Schein.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.97 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.97. Henry Schein had a return on equity of 19.70% and a net margin of 3.26%. The firm had revenue of $3.32 billion for the quarter, compared to analysts’ expectations of $3.30 billion. During the same period last year, the firm earned $0.94 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year.
Hedge funds have recently added to or reduced their stakes in the company. Jane Street Group LLC lifted its holdings in shares of Henry Schein by 353.7% during the fourth quarter. Jane Street Group LLC now owns 44,893 shares of the company’s stock valued at $3,138,000 after purchasing an additional 34,999 shares during the last quarter. Laurel Grove Capital LLC raised its holdings in Henry Schein by 39.6% in the 4th quarter. Laurel Grove Capital LLC now owns 17,241 shares of the company’s stock worth $1,205,000 after acquiring an additional 4,891 shares during the last quarter. Neuberger Berman Group LLC raised its holdings in Henry Schein by 95.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock worth $202,930,000 after acquiring an additional 1,211,743 shares during the last quarter. AXA raised its holdings in Henry Schein by 513.5% in the 4th quarter. AXA now owns 624,368 shares of the company’s stock worth $43,631,000 after acquiring an additional 522,600 shares during the last quarter. Finally, FDx Advisors Inc. raised its holdings in Henry Schein by 13.8% in the 4th quarter. FDx Advisors Inc. now owns 11,609 shares of the company’s stock worth $811,000 after acquiring an additional 1,409 shares during the last quarter. Hedge funds and other institutional investors own 98.32% of the company’s stock.
Shares of NASDAQ:HSIC traded up $0.96 on Wednesday, reaching $69.94. 1,270,800 shares of the company traded hands, compared to its average volume of 1,917,721. Henry Schein has a 52 week low of $62.56 and a 52 week high of $93.50. The stock has a market capitalization of $10,644.03, a P/E ratio of 19.19, a price-to-earnings-growth ratio of 1.68 and a beta of 1.05. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 0.32.
TRADEMARK VIOLATION WARNING: “Zacks: Analysts Anticipate Henry Schein, Inc. (HSIC) to Post $0.92 Earnings Per Share” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/04/16/zacks-analysts-anticipate-henry-schein-inc-hsic-to-post-0-92-earnings-per-share.html.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.